• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估老年肌少症干预措施疗效的临床前模型的有用性。

Usefulness of preclinical models for assessing the efficacy of late-life interventions for sarcopenia.

机构信息

Department of Aging and Geriatric Research, Institute on Aging, University of Florida, Gainesville, FL 32610, USA.

出版信息

J Gerontol A Biol Sci Med Sci. 2012 Jan;67(1):17-27. doi: 10.1093/gerona/glr042. Epub 2011 Jun 2.

DOI:10.1093/gerona/glr042
PMID:21636833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3260483/
Abstract

Caloric restriction and physical exercise have proven beneficial against age-associated changes in body composition and declining physical performance; however, little is known regarding what benefit these interventions might have when initiated late in life. The study of mimetics of diet and exercise and the combination thereof may provide additional treatments for a vulnerable elderly population; however, how and when to initiate such interventions requires consideration in developing the most safe and efficacious treatment strategies. In this review, we focus on preclinical late-life intervention studies, which assess the relationship between physical function, sarcopenia, and body composition. We provide a conceptual framework for the ever-changing definition of sarcopenia and a rationale for the use of an appropriate rodent model of this condition. We finish by providing our perspective regarding the implications of this body of work and future areas of research that may also contribute to the ultimate goal of extending healthspan.

摘要

热量限制和体育锻炼已被证明对与年龄相关的身体成分变化和身体机能下降有积极作用;然而,对于这些干预措施在生命晚期开始时可能会有什么益处,我们知之甚少。模拟饮食和运动及其组合的研究可能为脆弱的老年人群提供额外的治疗方法;然而,如何以及何时开始这些干预措施需要在制定最安全和最有效的治疗策略时加以考虑。在这篇综述中,我们重点关注评估身体机能、肌肉减少症和身体成分之间关系的生命后期干预的临床前研究。我们为不断变化的肌肉减少症定义提供了一个概念框架,并为使用这种疾病的适当啮齿动物模型提供了一个基本原理。最后,我们就这方面工作的意义以及未来可能有助于延长健康寿命的研究领域提出了我们的看法。

相似文献

1
Usefulness of preclinical models for assessing the efficacy of late-life interventions for sarcopenia.评估老年肌少症干预措施疗效的临床前模型的有用性。
J Gerontol A Biol Sci Med Sci. 2012 Jan;67(1):17-27. doi: 10.1093/gerona/glr042. Epub 2011 Jun 2.
2
The effect of circuit resistance training, empagliflozin or "vegeterranean diet" on physical and metabolic function in older subjects with type 2 diabetes: a study protocol for a randomized control trial (CEV-65 trial).电路电阻训练、恩格列净或“素食饮食”对 2 型糖尿病老年患者身体和代谢功能影响的随机对照试验研究方案(CEV-65 试验)。
BMC Geriatr. 2019 Aug 22;19(1):228. doi: 10.1186/s12877-019-1219-7.
3
Animal models of cachexia and sarcopenia in chronic illness: Cardiac function, body composition changes and therapeutic results.慢性病恶病质和肌肉减少症的动物模型:心脏功能、身体成分变化及治疗结果。
Int J Cardiol. 2017 Jul 1;238:12-18. doi: 10.1016/j.ijcard.2017.03.154. Epub 2017 Apr 2.
4
Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty - a mini-review.骨骼肌细胞凋亡:干预肌肉减少症和身体虚弱的潜在靶点——小型综述。
Gerontology. 2012;58(2):99-106. doi: 10.1159/000330064. Epub 2011 Sep 23.
5
Differential effects of calorie restriction and rapamycin on age-related molecular and functional changes in skeletal muscle.热量限制和雷帕霉素对骨骼肌与年龄相关的分子和功能变化的影响差异。
Exp Gerontol. 2022 Aug;165:111841. doi: 10.1016/j.exger.2022.111841. Epub 2022 May 25.
6
Energetic interventions for healthspan and resiliency with aging.针对健康寿命和衰老恢复力的活力干预措施。
Exp Gerontol. 2016 Dec 15;86:73-83. doi: 10.1016/j.exger.2016.05.012. Epub 2016 May 31.
7
A network pharmacology approach reveals new candidate caloric restriction mimetics in C. elegans.一种网络药理学方法揭示了秀丽隐杆线虫中热量限制模拟物的新候选物。
Aging Cell. 2016 Apr;15(2):256-66. doi: 10.1111/acel.12432. Epub 2015 Dec 16.
8
Lifespan-extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms.延长寿命的热量限制或mTOR抑制通过不同机制损害老年小鼠的适应性免疫。
Aging Cell. 2015 Feb;14(1):130-8. doi: 10.1111/acel.12280. Epub 2014 Nov 26.
9
Muscle quality in aging: a multi-dimensional approach to muscle functioning with applications for treatment.衰老过程中的肌肉质量:一种针对肌肉功能的多维研究方法及其治疗应用
Sports Med. 2015 May;45(5):641-58. doi: 10.1007/s40279-015-0305-z.
10
Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives.肌肉减少性肥胖:流行病学证据、病理生理学和治疗观点。
Curr Obes Rep. 2019 Dec;8(4):458-471. doi: 10.1007/s13679-019-00359-9.

引用本文的文献

1
Cellular and transcriptomic changes by the supplementation of aged rat serum in human pluripotent stem cell-derived myogenic progenitors.在人多能干细胞衍生的成肌祖细胞中补充老年大鼠血清所引起的细胞和转录组变化。
Front Cell Dev Biol. 2024 Oct 15;12:1481491. doi: 10.3389/fcell.2024.1481491. eCollection 2024.
2
Angiotensin (1-7) Delivered Orally via Probiotic in Combination With Exercise: Sex-Dependent Influence on Health Span.口服给予血管紧张素 (1-7) 结合运动的益生菌:对健康跨度的性别依赖性影响。
J Gerontol A Biol Sci Med Sci. 2023 Feb 24;78(2):223-226. doi: 10.1093/gerona/glac198.
3
Interactive Effects of Enalapril Administration and Novel HIIT Wheel-Bed Training in Aged Rats.依那普利给药与新型高强度间歇训练式轮床训练对老年大鼠的交互作用
Front Rehabil Sci. 2021 Nov;2. doi: 10.3389/fresc.2021.764686. Epub 2021 Nov 8.
4
ngiotensin Converting Enzyme Inhibitors ombined with xercise for Hypertensive eniors (The ACES Trial): Study Protocol of a Randomized Controlled Trial.血管紧张素转换酶抑制剂联合运动治疗老年高血压患者(ACES试验):一项随机对照试验的研究方案
Front Med (Lausanne). 2020 Jan 22;6:327. doi: 10.3389/fmed.2019.00327. eCollection 2019.
5
Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide.烟酰胺的多种治疗功效和更多样化的作用机制。
Metabolomics. 2019 Oct 5;15(10):137. doi: 10.1007/s11306-019-1604-4.
6
Multimodal Intervention to Improve Functional Status in Hypertensive Older Adults: A Pilot Randomized Controlled Trial.多模式干预改善老年高血压患者功能状态:一项随机对照试验的初步研究
J Clin Med. 2019 Feb 6;8(2):196. doi: 10.3390/jcm8020196.
7
Muscle function decline and mitochondria changes in middle age precede sarcopenia in mice.中年小鼠的肌肉功能衰退和线粒体变化先于肌肉减少症出现。
Aging (Albany NY). 2018 Jan 4;10(1):34-55. doi: 10.18632/aging.101358.
8
Antihypertensive Use and the Effect of a Physical Activity Intervention in the Prevention of Major Mobility Disability Among Older Adults: The LIFE Study.降压药物的使用及体力活动干预对预防老年人严重活动障碍的影响:LIFE研究
J Gerontol A Biol Sci Med Sci. 2016 Jul;71(7):974-81. doi: 10.1093/gerona/glv222. Epub 2016 Feb 10.
9
Hypertension and aging.高血压与衰老
Ageing Res Rev. 2016 Mar;26:96-111. doi: 10.1016/j.arr.2016.01.007. Epub 2016 Feb 1.
10
Successful aging: Advancing the science of physical independence in older adults.成功老龄化:推进老年人身体独立的科学研究。
Ageing Res Rev. 2015 Nov;24(Pt B):304-27. doi: 10.1016/j.arr.2015.09.005. Epub 2015 Oct 14.

本文引用的文献

1
Gait speed and survival in older adults.老年人的步速与生存。
JAMA. 2011 Jan 5;305(1):50-8. doi: 10.1001/jama.2010.1923.
2
Differential effects of enalapril and losartan on body composition and indices of muscle quality in aged male Fischer 344 × Brown Norway rats.依那普利和氯沙坦对老年雄性Fischer 344×Brown Norway大鼠身体成分和肌肉质量指标的不同影响。
Age (Dordr). 2011 Jun;33(2):167-83. doi: 10.1007/s11357-010-9196-y. Epub 2010 Dec 14.
3
Protection against age-dependent renal injury in the F344xBrown Norway male rat is associated with maintained nitric oxide synthase.保护 F344xBrown Norway 雄性大鼠免受年龄相关的肾损伤与维持一氧化氮合酶有关。
Mech Ageing Dev. 2011 Jan-Feb;132(1-2):1-7. doi: 10.1016/j.mad.2010.10.004. Epub 2010 Nov 16.
4
Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy.CALERIE 研究的设计和实施:能量摄入减少对长期影响的综合评估。
J Gerontol A Biol Sci Med Sci. 2011 Jan;66(1):97-108. doi: 10.1093/gerona/glq168. Epub 2010 Oct 5.
5
The act of voluntary wheel running reverses dietary hyperphagia and increases leptin signaling in ventral tegmental area of aged obese rats.自愿转轮运动可逆转饮食性暴食,并增加老年肥胖大鼠腹侧被盖区的瘦素信号。
Gerontology. 2011;57(4):335-42. doi: 10.1159/000321343. Epub 2010 Sep 24.
6
The demographic and biomedical case for late-life interventions in aging.老龄化背景下的晚年干预的人口统计学和生物医学案例。
Sci Transl Med. 2010 Jul 14;2(40):40cm21. doi: 10.1126/scitranslmed.3000822.
7
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.肌肉减少症:欧洲定义和诊断共识:老年人肌肉减少症欧洲工作组报告。
Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.
8
Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.慢性雷帕霉素治疗通过上调肝脏糖异生和损害脂肪组织中的脂质沉积导致葡萄糖不耐受和高脂血症。
Diabetes. 2010 Jun;59(6):1338-48. doi: 10.2337/db09-1324. Epub 2010 Mar 18.
9
Multiple pathways to the same end: mechanisms of myonuclear apoptosis in sarcopenia of aging.殊途同归:衰老性肌肉减少症中肌核凋亡的机制
ScientificWorldJournal. 2010 Feb 19;10:340-9. doi: 10.1100/tsw.2010.27.
10
Functional consequences of sarcopenia and dynapenia in the elderly.老年人肌少症和无力症的功能后果。
Curr Opin Clin Nutr Metab Care. 2010 May;13(3):271-6. doi: 10.1097/MCO.0b013e328337819e.